KRYS
Krystal Biotech Inc
Price:  
185.74 
USD
Volume:  
249,337.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KRYS WACC - Weighted Average Cost of Capital

The WACC of Krystal Biotech Inc (KRYS) is 8.0%.

The Cost of Equity of Krystal Biotech Inc (KRYS) is 12.30%.
The Cost of Debt of Krystal Biotech Inc (KRYS) is 5.00%.

Range Selected
Cost of equity 7.90% - 16.70% 12.30%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.8% - 10.2% 8.0%
WACC

KRYS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.88 2.12
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 16.70%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.8% 10.2%
Selected WACC 8.0%